- The trend backdrop is active with a 16-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6748
TWO
Week ended 14 Aug 2026
Weekly Investor Report
ACRO Biomedical Co., Ltd. · Healthcare · Biotechnology
Latest close
173.0 TWD
-12.6%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 68.2% above the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned -12.6%, after a -33.6% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
59
out of 100
Latest Close
173.0 TWD
14 Aug 2026
1W Return
-12.6%
latest completed week
4W Return
-33.6%
short-term follow-through
12W Return
150.0%
quarterly tape
Trend Breadth
71.2%
37 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Next-week expectancy is negative at 43.44% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-12.6%
Latest completed week; four-week move -33.6%.
Indicator stack
84/57
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.44%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 68.2% above the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned -12.6%, after a -33.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9812-week average 0.83
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -33.6% over four weeks, 150.0% over 12 weeks, and 113.3% over one year. The current trend has remained active for 16 consecutive weeks.
Performance by holding period
Active trend streak16 weeks
Active weeks in one year37
Trend breadth71.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.68Latest activity-pressure read.
Pressure change-61.2%Four-week change in activity pressure.
Leadership47.64Latest relative-leadership reading.
RS change-67.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-44.2%Distance below the 52-week high.
13-week volatility22.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+49.1%Week of 5 Jun.
Worst week-32.2%Week of 24 Jul.
Latest week-12.6%Week of 14 Aug.
Shape of recent returns
Strong gains10
Modest gains3
Flat weeks0
Modest losses7
Sharp losses6
Recent vol22.9%13-week weekly-return volatility.
Base vol13.1%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew12.0% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank99 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank95 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis90/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.
Activity pressure 0.98; No reversal markers Next-Week ExpectancyNegative 43.44%Next-week expectancy is negative with a 43.44% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 173.0 TWD | -12.6% | 102.8 TWD | 52.28 TWD | 0.68 | 47.64 | 4.1M | On |
| 7 Aug 2026 | 198.0 TWD | 18.6% | 99.20 TWD | 51.44 TWD | 1.05 | 75.56 | 4.8M | On |
| 31 Jul 2026 | 167.0 TWD | -5.4% | 94.77 TWD | 50.46 TWD | 1.32 | 52.84 | 4.3M | On |
| 24 Jul 2026 | 176.5 TWD | -32.2% | 91.42 TWD | 49.63 TWD | 1.59 | 60.95 | 8.9M | On |
| 17 Jul 2026 | 260.5 TWD | 40.1% | 87.65 TWD | 48.72 TWD | 1.74 | 145.71 | 10.2M | On |
| 10 Jul 2026 | 186.0 TWD | 22.4% | 81.14 TWD | 47.25 TWD | 1.73 | 70.90 | 6.7M | On |
| 3 Jul 2026 | 152.0 TWD | -9.5% | 77.24 TWD | 46.28 TWD | 1.74 | 38.00 | 4.6M | On |
| 26 Jun 2026 | 168.0 TWD | 41.8% | 74.26 TWD | 45.49 TWD | 1.79 | 62.36 | 6.6M | On |
| 19 Jun 2026 | 118.5 TWD | -0.8% | 70.64 TWD | 44.59 TWD | 1.70 | 11.88 | 5.4M | On |
| 12 Jun 2026 | 119.5 TWD | 8.1% | 68.65 TWD | 44.02 TWD | 1.25 | 19.57 | 8.6M | On |
| 5 Jun 2026 | 110.5 TWD | 49.1% | 66.79 TWD | 43.42 TWD | 0.95 | 9.24 | 6.8M | On |
| 29 May 2026 | 74.10 TWD | 7.1% | 65.27 TWD | 42.88 TWD | 0.75 | -25.74 | 3.0M | On |
| 22 May 2026 | 69.20 TWD | 1.2% | 65.12 TWD | 42.56 TWD | 0.66 | -26.64 | 1.1M | On |
| 15 May 2026 | 68.40 TWD | -3.7% | 65.15 TWD | 42.28 TWD | 0.96 | -25.59 | 1.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.